EE04494B1 - 1-Oxa, aza and thianaphthalen-2-one biseters as phospholambane inhibitors - Google Patents

1-Oxa, aza and thianaphthalen-2-one biseters as phospholambane inhibitors

Info

Publication number
EE04494B1
EE04494B1 EEP200000179A EEP200000179A EE04494B1 EE 04494 B1 EE04494 B1 EE 04494B1 EE P200000179 A EEP200000179 A EE P200000179A EE P200000179 A EEP200000179 A EE P200000179A EE 04494 B1 EE04494 B1 EE 04494B1
Authority
EE
Estonia
Prior art keywords
thianaphthalen
phospholambane
biseters
aza
oxa
Prior art date
Application number
EEP200000179A
Other languages
Estonian (et)
Inventor
Johannes Karjalainen Arto
Pystynen Jarmo
Tiainen Eija
L�nnberg Kari
Nore Pentti
Parhi Seppo
Haikala Heimo
Levijoki Jouko
Original Assignee
Orion Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corporation filed Critical Orion Corporation
Publication of EE200000179A publication Critical patent/EE200000179A/en
Publication of EE04494B1 publication Critical patent/EE04494B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/16Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
EEP200000179A 1997-09-24 1998-09-24 1-Oxa, aza and thianaphthalen-2-one biseters as phospholambane inhibitors EE04494B1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US93711997A 1997-09-24 1997-09-24
US99015097A 1997-12-12 1997-12-12
US10411498A 1998-06-25 1998-06-25
PCT/FI1998/000755 WO1999015523A1 (en) 1997-09-24 1998-09-24 Bisethers of 1-oxa, aza and thianaphthalen-2-ones as phospholamban inhibitors

Publications (2)

Publication Number Publication Date
EE200000179A EE200000179A (en) 2001-04-16
EE04494B1 true EE04494B1 (en) 2005-06-15

Family

ID=27379660

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000179A EE04494B1 (en) 1997-09-24 1998-09-24 1-Oxa, aza and thianaphthalen-2-one biseters as phospholambane inhibitors

Country Status (18)

Country Link
EP (1) EP1017691A1 (en)
JP (1) JP2003525838A (en)
KR (1) KR20010015607A (en)
CN (1) CN1143857C (en)
AU (1) AU735729B2 (en)
BR (1) BR9813216A (en)
CA (1) CA2304849A1 (en)
EA (1) EA003084B1 (en)
EE (1) EE04494B1 (en)
HU (1) HUP0003647A3 (en)
ID (1) ID24373A (en)
IL (1) IL134662A0 (en)
NO (1) NO20001569D0 (en)
NZ (1) NZ503044A (en)
PL (1) PL339493A1 (en)
SK (1) SK3902000A3 (en)
TR (1) TR200000764T2 (en)
WO (1) WO1999015523A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001278980A1 (en) 2000-07-21 2002-02-05 Chugai Seiyaku Kabushiki Kaisha Coumarin derivatives useful as tnfalpha inhibitors
CA2442476A1 (en) * 2001-03-30 2002-10-10 Pfizer Products Inc. Pyridazinone aldose reductase inhibitors
US7572910B2 (en) 2003-02-20 2009-08-11 Pfizer, Inc. Pyridazinone aldose reductase inhibitors
FR2970964B1 (en) * 2011-01-28 2013-12-13 Univ Claude Bernard Lyon NOVEL AZACOUMARIN DERIVATIVES WITH INHIBITOR ACTIVITY OF MDR PUMPS

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2543945A1 (en) * 1975-10-02 1977-04-21 Troponwerke Gmbh & Co Kg Coronary dilator 2-benzopyranones, active by enteral admin. - contg. trimethoxybenzoyl or trimethoxycinnamoyl substits.
GB8529362D0 (en) * 1985-11-28 1986-01-02 Pfizer Ltd Quinolone cardiac stimulants
GB8630702D0 (en) * 1986-12-23 1987-02-04 Wellcome Found Quinoline compound
US5053514A (en) * 1988-08-10 1991-10-01 Otsuka Pharmaceutical Company, Limited Cardiotonics
CA2022236A1 (en) * 1989-07-31 1991-02-01 Hiroaki Yanagisawa Coumarin derivatives, their preparation and their use in the treatment of cerebrovascular disorders
DE4337906A1 (en) * 1993-11-08 1995-05-11 Cassella Ag Use of coumarin derivatives

Also Published As

Publication number Publication date
CN1143857C (en) 2004-03-31
KR20010015607A (en) 2001-02-26
EE200000179A (en) 2001-04-16
NZ503044A (en) 2001-08-31
CN1271357A (en) 2000-10-25
NO20001569L (en) 2000-03-24
SK3902000A3 (en) 2000-12-11
WO1999015523A1 (en) 1999-04-01
AU735729B2 (en) 2001-07-12
NO20001569D0 (en) 2000-03-24
AU9350898A (en) 1999-04-12
EP1017691A1 (en) 2000-07-12
HUP0003647A2 (en) 2001-08-28
EA003084B1 (en) 2002-12-26
IL134662A0 (en) 2001-04-30
EA200000352A1 (en) 2000-10-30
HUP0003647A3 (en) 2002-12-28
BR9813216A (en) 2000-08-29
JP2003525838A (en) 2003-09-02
ID24373A (en) 2000-07-13
CA2304849A1 (en) 1999-04-01
TR200000764T2 (en) 2001-03-21
PL339493A1 (en) 2000-12-18

Similar Documents

Publication Publication Date Title
NO982686D0 (en) R ° rledningsplugg
NO975894L (en) Foringsr ° rpakning
ATE271543T1 (en) N-SUBSTITUTED 2-CYANOPYRROLIDINE
DK1027332T3 (en) New lactametalloprotease inhibitors
DE69837355D1 (en) Bola
DK0958287T3 (en) Sulfamidmetalloprotease inhibitors
NO983187L (en) Substituted aza and diazacycloheptane and cyclooctane compound and their use
NO996578D0 (en) Urokinase inhibitors
ID22380A (en) PIRAZOL DAMAGES AS HERBISIDES
NO984771D0 (en) F ° lgesystem
TR199800117A3 (en) Isaksazol- and crotonacitamide derivatives and their use.
NO984662D0 (en) Water-in-oil emulsjonsgj ° dningsstoffsammensetninger
PT1023268E (en) ISOKINOLINES AS UROQUINASE INHIBITORS
IT1303916B1 (en) NONILATED DIPHENYLAMINES
NO992852D0 (en) Basisstr ° mningsenhet
NO305410B1 (en) B ° lgekraftverk
EE04494B1 (en) 1-Oxa, aza and thianaphthalen-2-one biseters as phospholambane inhibitors
NO20003268L (en) Hyperhydrated chiticoline, method and use
NO974892L (en) Ventilasjonsr ° r
BR9707943B (en) COMPOUND AND GLUTARIMIDE
DE60005282D1 (en) GOLFSCHLÄGERKOPF, GOLFSCHLÄGER AND GOLFSCHLÄGERSET
FI972885A0 (en) Anordning Foer utfoering av en divisionoperation, saerskilt i en tredimensionell grafik
DE29805515U1 (en) Cradle
NO970249L (en) N ° dlys
FI971570A0 (en) Styrsystem Foer foerbraenningsluften i en acumulerande, vedeldad eldstad

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20051231

MM4A Lapsed by not paying the annual fees

Effective date: 20050924